Effects of krill oil and lean and fatty fish on cardiovascular risk markers: A randomised controlled trial

Journal of Nutritional Science

Volumn 7, Issue , 2018, Pages

  Rundblad, Amanda ^a   Holven, Kirsten B ^b,c   Bruheim, Inge ^d   Myhrstad, Mari C ^a   Ulven, Stine M ^b  

^a OSLO METROPOLITAN UNIVERSITY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d RimfrostAS   (Norway)

Author keywords

DHA; Docosapentaenoic acid; EPA; Fish; Krill oil; Lipoprotein subclasses; TAG

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ARACHIDONIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; DOCOSAPENTAENOIC ACID; FISH OIL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KRILL OIL; LINOLEIC ACID; LIOTHYRONINE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRISTIC ACID; OLEIC ACID; OMEGA 3 FATTY ACID; PALMITIC ACID; PHOSPHOLIPID; STEARIC ACID; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; VITAMIN D;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTHRALGIA; ARTICLE; BLOATING; CALORIC INTAKE; CARBOHYDRATE INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIETARY COMPLIANCE; DIETARY FIBER; DIETARY SUPPLEMENT; DIZZINESS; ERUCTATION; ESTIMATED GLOMERULAR FILTRATION RATE; FAT INTAKE; FATIGUE; FEMALE; FISH; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEADACHE; HUMAN; HUMAN EXPERIMENT; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; SUGAR INTAKE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; URINE COLOR; VITAMIN BLOOD LEVEL; VOMITING;

EID: 85040785426     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2017.64     Document Type: Article

References (70)

1. Gruppo Italiano Per Lo Studio Della Sopravvivenza Nell'Infarto Miocardio-Heart Failure (GISSI-HF) Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-prevenzione trial. Lancet 354, 447-455.
2. Yokoyama M, Origasa H, Matsuzaki M, et al. (2007) Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 369, 1090-1098.
3. Tavazzi L, Maggioni AP, Marchioli R, et al. (2008) Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebocontrolled trial. Lancet 372, 1223-1230.
4. He K, Song Y, Daviglus ML, et al. (2004) Accumulated evidence on fish consumption and coronary heart disease mortality: A meta-analysis of cohort studies. Circulation 109, 2705-2711.
5. Burr ML, Fehily AM, Gilbert JF, et al. (1989) Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet ii, 757-761.
6. Konig A, Bouzan C, Cohen JT, et al. (2005) A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med 29, 335-346.
7. Casula M, Soranna D, Catapano AL, et al. (2013) Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected]. Atheroscler Suppl 14, 243-251.
8. Roncaglioni MC, Tombesi M, Avanzini F, et al. (2013) n-3 Fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368, 1800-1808.
9. Rizos EC, Ntzani EE, Bika E, et al. (2012) Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 308, 1024-1033.
10. Alexander DD, Miller PE, Van Elswyk ME, et al. (2017) A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc 92, 15-29.
11. Calder PC (2012) Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology Br J Clin Pharmacol 75, 645-662.
12. Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, 1645s-1654s.
13. Morris MC, Sacks F & Rosner B (1993) Does fish oil lower blood pressure A meta-analysis of controlled trials. Circulation 88, 523-533.
14. Thies F, Garry JM, Yaqoob P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: A randomised controlled trial. Lancet 361, 477-485.
15. Saravanan P, Davidson NC, Schmidt EB, et al. (2010) Cardiovascular effects of marine omega-3 fatty acids. Lancet 376, 540-550.
16. Geleijnse JM, Giltay EJ, Grobbee DE, et al. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 20, 1493-1499.
17. Balk EM, Lichtenstein AH, Chung M, et al. (2006) Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review. Atherosclerosis 189, 19-30.
18. Nordestgaard BG & Varbo A (2014) Triglycerides and cardiovascular disease. Lancet 384, 626-635.
19. Lund EK (2013) Health benefits of seafood; is it just the fatty acids Food Chem 140, 413-420.
20. Kris-Etherton PM, Harris WS & Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
21. Lichtenstein AH, Appel LJ, Brands M, et al. (2006) Summary of American Heart Association diet and lifestyle recommendations revision 2006. Arterioscler Thromb Vasc Biol 26, 2186-2191.
22. Helsedirektoratet (2011) Kostråd for å fremme folkehelsen og forebygge kroniske sykdommer. Metodologi og vitenskaplig grunnlag. Nasjonalt råd for ernæring 2011 (Dietary guidelines to promote public health and prevent chronic diseases. Methodology and scientific basis. National Nutrition Council 2011). https://helsedirektoratet. no/publikasjoner/kostrad-for-a-fremme-folkehelsen-og-forebyggekroniske-sykdommer-metodologi-og-vitenskapelig-kunnskapsgrunnlag (accessed May 2017).
23. Erkkila AT, Schwab US, de Mello VD, et al. (2008) Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications. Eur J Nutr 47, 319-328.
24. Aadland EK, Lavigne C, Graff IE, et al. (2015) Lean-seafood intake reduces cardiovascular lipid risk factors in healthy subjects: results from a randomized controlled trial with a crossover design. Am J Clin Nutr 102, 582-592.
25. Leaf DA & Hatcher L (2009) The effect of lean fish consumption on triglyceride levels. Phys Sportsmed 37, 37-43.
26. Telle-Hansen VH, Larsen LN, Hostmark AT, et al. (2012) Daily intake of cod or salmon for 2 weeks decreases the 18:1n-9/18:0 ratio and serum triacylglycerols in healthy subjects. Lipids 47, 151-160.
27. Nicol S, Foster J & Kawaguchi S (2012) The fishery for Antarctic krill-recent developments. Fish Fisheries 13, 30-40.
28. Tou JC, Jaczynski J & Chen YC (2007) Krill for human consumption: nutritional value and potential health benefits. Nutr Rev 65, 63-77.
29. Bunea R, El Farrah K & Deutsch L (2004) Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia. Altern Med Rev 9, 420-428.
30. Maki KC, Reeves MS, Farmer M, et al. (2009) Krill oil supplementation increases plasma concentrations of eicosapentaenoic and docosahexaenoic acids in overweight and obese men and women. Nutr Res 29, 609-615.
31. Ramprasath VR, Eyal I, Zchut S, et al. (2013) Enhanced increase of omega-3 index in healthy individuals with response to 4-week n-3 fatty acid supplementation from krill oil versus fish oil. Lipids Health Dis 12, 178.
32. Ulven SM, Kirkhus B, Lamglait A, et al. (2011) Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids 46, 37-46.
33. Ulven SM & Holven KB (2015) Comparison of bioavailability of krill oil versus fish oil and health effect. Vasc Health Risk Manag 11, 511-524.
34. Krauss RM (2010) Lipoprotein subfractions and cardiovascular disease risk. Curr Opin Lipidol 21, 305-311.
35. Freedman DS, Otvos JD, Jeyarajah EJ, et al. (1998) Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 18, 1046-1053.
36. Soininen P, Kangas AJ, Wurtz P, et al. (2015) Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet 8, 192-206.
37. Erkkila AT, Schwab US, Lehto S, et al. (2014) Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial. J Clin Lipidol 8, 126-133.
38. Lankinen M, Kolehmainen M, Jaaskelainen T, et al. (2014) Effects of whole grain, fish and bilberries on serum metabolic profile andlipid transfer protein activities: A randomized trial (Sysdimet). PLOS ONE 9, e90352.
39. Mostad IL, Bjerve KS, Lydersen S, et al. (2008) Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes. Eur J Clin Nutr 62, 419-429.
40. Carlsen MH, Lillegaard IT, Karlsen A, et al. (2010) Evaluation of energy and dietary intake estimates from a food frequency questionnaire using independent energy expenditure measurement and weighed food records. Nutr J 9, 37.
41. Rundblad A, Holven KB, Ottestad I, et al. (2017) High-quality fish oil has a more favourable effect than oxidised fish oil on intermediate-density lipoprotein and LDL subclasses: A randomised controlled trial. Br J Nutr 117, 1291-1298.
42. Ottestad I, Nordvi B, Vogt G, et al. (2016) Bioavailability of n-3 fatty acids from n-3-enriched foods and fish oil with different oxidative quality in healthy human subjects: A randomised single-meal cross-over study. J Nutr Sci 5, e43.
43. Kuriki K, Nagaya T, Tokudome Y, et al. (2003) Plasma concentrations of (n-3) highly unsaturated fatty acids are good biomarkers of relative dietary fatty acid intakes: A cross-sectional study. J Nutr 133, 3643-3650.
44. Marklund M, Magnusdottir OK, Rosqvist F, et al. (2014) A dietary biomarker approach captures compliance and cardiometabolic effects of a healthy Nordic diet in individuals with metabolic syndrome. J Nutr 144, 1642-1649.
45. Telle-Hansen VH, Narverud I, Retterstol K, et al. (2012) Substitution of TAG oil with diacylglycerol oil in food items improves the predicted 10 years cardiovascular risk score in healthy, overweight subjects. J Nutr Sci 1, e17.
46. Berge RK, Ramsvik MS, Bohov P, et al. (2015) Krill oil reduces plasma triacylglycerol level and improves related lipoprotein particle concentration, fatty acid composition and redox status in healthy young adults-a pilot study. Lipids Health Dis 14, 163.
47. R Development Core Team (2016) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
48. Berge K, Musa-Veloso K, Harwood M, et al. (2014) Krill oil supplementation lowers serum triglycerides without increasing lowdensity lipoprotein cholesterol in adults with borderline high or high triglyceride levels. Nutr Res 34, 126-133.
49. Berge K, Piscitelli F, Hoem N, et al. (2013) Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids Health Dis 12, 78.
50. Cormier H, Rudkowska I, Paradis AM, et al. (2012) Association between polymorphisms in the fatty acid desaturase gene cluster and the plasma triacylglycerol response to an n-3 PUFA supplementation. Nutrients 4, 1026-1041.
51. Caslake MJ, Miles EA, Kofler BM, et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: The FINGEN study. Am J Clin Nutr 88, 618-629.
52. Vallée Marcotte B, Cormier H, Guénard F, et al. (2016) Novel genetic loci associated with the plasma triglyceride response to an omega-3 fatty acid supplementation. J Nutrigenet Nutrigenomics 9, 1-11.
53. Park Y & Harris WS (2003) Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44, 455-463.
54. Rye KA & Barter PJ (2014) Regulation of high-density lipoprotein metabolism. Circ Res 114, 143-156.
55. Tzoulaki I, Elliott P, Kontis V, et al. (2016) Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps. Circulation 133, 2314-2333.
56. Ross S, Gerstein HC, Eikelboom J, et al. (2015) Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease. Eur Heart J 36, 1454-1462.
57. Ferramosca A, Conte A, Burri L, et al. (2012) A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats. PLOS ONE 7, e38797.
58. Ivanova Z, Bjorndal B, Grigorova N, et al. (2015) Effect of fish and krill oil supplementation on glucose tolerance in rabbits with experimentally induced obesity. Eur J Nutr 54, 1055-1067.
59. Tandy S, Chung RW, Wat E, et al. (2009) Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice. J Agric Food Chem 57, 9339-9345.
60. Bjorndal B, Vik R, Brattelid T, et al. (2012) Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-transgenic mice fed a high-fat diet. Metabolism 61, 1461-1472.
61. Burri L, Berge K, Wibrand K, et al. (2011) Differential effects of krill oil and fish oil on the hepatic transcriptome in mice. Front Genet 2, 45.
62. Rudkowska I (2010) Fish oils for cardiovascular disease: impact on diabetes. Maturitas 67, 25-28.
63. Scragg R, Jackson R, Holdaway IM, et al. (1990) Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol 19, 559-563.
64. Poole KE, Loveridge N, Barker PJ, et al. (2006) Reduced vitamin D in acute stroke. Stroke 37, 243-245.
65. Wang TJ, Pencina MJ, Booth SL, et al. (2008) Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511.
66. Kendrick J, Targher G, Smits G, et al. (2009) 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 205, 255-260.
67. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
68. Lehmann U, Gjessing HR, Hirche F, et al. (2015) Efficacy of fish intake on vitamin D status: A meta-analysis of randomized controlled trials. Am J Clin Nutr 102, 837-847.
69. Lu Z, Chen TC, Zhang A, et al. (2007) An evaluation of the vitamin D3 content in fish: is the vitamin D content adequate to satisfy the dietary requirement for vitamin D J Steroid Biochem Mol Biol 103, 642-644.
70. Arab L (2003) Biomarkers of fat and fatty acid intake. J Nutr 133, Suppl. 3, 925s-932s.